Stay updated on STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The update appears to include non-substantive changes such as updated Study Record Dates and minor formatting; core study content (interventions, eligibility criteria, endpoints) remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T13:43:08.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    35 days ago
    Change Detected
    Summary
    Core content updated: adds a funding-lapse notice with open status for the NIH Clinical Center and directs to status sites; replaces version v3.1.0 with v3.2.0.
    Difference
    3%
    Check dated 2025-10-06T04:24:19.000Z thumbnail image
  4. Check
    42 days ago
    Change Detected
    Summary
    Updates add new date/version metadata (2025-09-22, 2025-09-18, Last Update Posted (Estimated), Revision: v3.1.0) and remove several older cancer-related topics (e.g., Ovarian cancer, Carcinoma, Neoplasms) leading to a narrowed content focus.
    Difference
    1%
    Check dated 2025-09-28T23:42:15.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    Version bumped from v3.0.1 to v3.0.2, signaling a new release. The 'Back to Top' control was removed, which is a UI change and does not affect core content.
    Difference
    0.2%
    Check dated 2025-09-14T09:58:22.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-07T07:48:33.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The web page has been updated to include a new facility name and location, along with a list of relevant publications from PubMed related to ovarian cancer. Additionally, several specific cancer types and drug categories have been removed.
    Difference
    9%
    Check dated 2025-08-31T01:06:17.000Z thumbnail image

Stay in the know with updates to STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial page.